---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-164486"
form_type: "8-K"
ticker: "SLDB"
cik: "0001707502"
company_name: "Solid Biosciences Inc."
filed_at: "2023-06-09T23:59:59+00:00"
generated_at: "2026-06-14T04:03:47.725127+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Solid Biosciences stockholders elect four Class II directors, ratify auditor, approve ESPP amendment

## Summary
- Elected Clare Kahn, Adam Koppel, Adam Stone, Lynne Sullivan as Class II directors to 2026; votes ranged 13.6M–14.2M for, 76K–664K withheld.
- Ratified PricewaterhouseCoopers LLP as auditor for FY 2023 with 15.3M for, 4.9K against, 5.5K abstain.
- Approved amendment to 2021 ESPP increasing shares available for issuance; 13.6M for, 679K against, 4K abstain.
- All results from June 6, 2023 Annual Meeting; broker non-votes of ~1.1M on director election and ESPP amendment.

## SEC filing metadata
- accession: 0001193125-23-164486
- form_type: 8-K
- ticker: SLDB
- cik: 0001707502
- company_name: Solid Biosciences Inc.
- filed_at: 2023-06-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1707502/000119312523164486/0001193125-23-164486-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1707502/000119312523164486/d513689d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-164486
- JSON: https://secwatch.observer/filing/0001193125-23-164486.json
- Plain text: https://secwatch.observer/filing/0001193125-23-164486.txt

## Key facts
- Shareholder Votes
  Solid Biosciences Inc. shareholders approved Election of Class II directors at the 2023-06-06 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: The Company held its Annual Meeting on June 6, 2023 to consider and vote upon the matters listed below.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1707502/000119312523164486/0001193125-23-164486-index.htm
- Shareholder Votes
  Solid Biosciences Inc. shareholders approved Amendment to the Company's 2021 Employee Stock Purchase Plan to increase number of shares available for issuance at the 2023-06-06 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: The Company’s stockholders approved an amendment to the Company’s 2021 Employee Stock Purchase Plan to increase the number of shares available for issuance thereunder.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1707502/000119312523164486/0001193125-23-164486-index.htm
- Shareholder Votes
  Solid Biosciences Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-06 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: The Company’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1707502/000119312523164486/0001193125-23-164486-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.